Orexigen Wins FDA Advisory Approval for Anti-Obesity Drug

Loading...
Loading...
Orexigen Therapeutics
OREX
achives FDA Advisory Board approval for their anti-obesity drug Contrave. PharmaDirections has been Orexigen's pharmaceutical development partner and has developed and produced the first Contrave product to undergo full clinical development.
Posted In: NewsFDABiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...